Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-02-23 @ 4:31 AM
Study NCT ID:
NCT05351593
Status:
RECRUITING
Last Update Posted:
2025-02-03
First Post:
2022-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma
Sponsor:
James Rubenstein
Organization: